DKTK/MASTER Whole-Genome/-Exome Sequencing - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

DeviceDefinition: DKTK/MASTER Whole-Genome/-Exome Sequencing

English

Profile: MII PR MTB Panel DeviceDefinition

DeviceNames

Name

Type

DKTK/MASTER Whole-Genome/-Exome Sequencing

User Friendly name

type: Genpanel

version: Stand 02-2026

capability
type: SNV-Detektion

capability
type: Fusions-Detektion

capability
type: Deletions-Detektion

capability
type: Amplifikations-Detektion

capability
type: Ueberexpressions-Detektion

capability
type: Signatur-Detektion

url: https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/DeviceDefinition/mii-dd-mtb-panel-master

onlineInformation: https://pathologie-ccm.charite.de/fileadmin/user_upload/microsites/m_cc05/pathologie-ccm/00_formulare_documente/00_molekularpathologie/Anlage_Genlisten_NGS-Panel.pdf

note:

Analyse im DKTK/MASTER-Programm; genomweit, keine endliche Panelliste (all_assessed).

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-15
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.